News | August 10, 2009

Liability Prompts Credentialing for Robotic Urological Surgery

August 11, 2009 - Despite a hurried rise in robotic urological surgery in the past 10 years as hospitals try to stay competitive in offering patients the latest technology, no standardized training or credentialing process is in place to test surgeon competency and safety with the da Vinci Robotic Surgical System, leaving many patients and medical centers at risk for error and injury. An article published in the September issue of the Journal of Urology recommends guidelines to safely implement robot-assisted radical prostatectomy (RARP), or robotic prostate cancer removal surgery.

According to the authors, two distinct forms of supervision need to be regulated during the learning curve period: proctoring, the observation and assessment by a more experienced surgeon of the novice surgeon; and preceptoring, an active, hands-on approach where the experienced surgeon assists a less experienced surgeon in new skills.

Zorn is a proctor; he has performed more than 500 RARPs. Surgeons at Weiss Memorial Hospital and its affiliated University of Chicago Medical Center have conducted more than 2,500 RUS procedures.

With an estimated 85 percent of all radical prostatectomies this year being performed robotically (more than double the number from just three years ago) and an estimated two new medical centers implementing a robot every week, the Society of Urologic Robotic Surgeons (SURS) suggests 11 parameters to assist hospitals and physicians to ensure safety and competence in credentialing surgeons. They include:

? Establishing a national certification authority that would institute and uphold standards for safe introduction of RARP and file follow-up reports to an institutional credentialing committee;

? Credentialing of institutions and individuals based on standards, including specific training, certification courses, departmental staffing and infrastructure;

? Increasing the number of regional centers to assist with preceptoring through mini-residency programs;

? Indemnifying the proctor against any possible legal implications while performing proctoring services for RARP; and

? Obtaining informed consent from the patient with regards to the role of the proctor during the surgery and thereafter.
The authors see one way of increasing the pool of available proctors to make these guidelines possible through telemedicine technology, which allows an expert surgeon stationed remotely to observe, oversee and actively supervise a procedure being conducted by a surgeon learner at his or her institution.
Bradley Schwartz, M.D., director of the Center for Laparoscopy, Endourology and Robotic Surgery and professor of urology at Southern Illinois University School of Medicine, who wrote an editorial in the Journal of Urology reviewing the article. He sees training and credentialing of surgeons paramount to the success of robotic surgery now and in the future.

For more information: and

Related Content

Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Overall survival of metastatic patients with SABR presented at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018
News | Radiation Oncology | October 30, 2018
October 30, 2018 — In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggre
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
CyberKnife System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
News | Stereotactic Body Radiation Therapy (SBRT) | September 27, 2018
Accuray Inc. announced that published data from two prospective, multi-center studies using differing protocols provide...
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
Age Impacts Post-treatment Mortality for Early-stage Lung Cancer Patients

Image courtesy of Henri Becquerel Cancer Center

News | Stereotactic Body Radiation Therapy (SBRT) | January 24, 2018
A University of Colorado Cancer Center study published in the Journal of Clinical Oncology explores mortality in the...
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...